Reply to: "Similar risk of hepatocellular carcinoma during long-term entecavir or tenofovir therapy in Caucasian patients with chronic hepatitis B"

被引：0
|
作者：
Papatheodoridis, George
Sypsa, Vana
Lampertico, Pietro
机构：
来源：
JOURNAL OF HEPATOLOGY | 2021年 / 74卷 / 01期
关键词：
D O I：
10.1016/j.jhep.2020.09.005
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：246 / 247
页数：3
相关论文
共 50 条
  • [41] OCCURRENCE OF HEPATOCELLULAR CARCINOMA IN CHRONIC HEPATITIS B PATIENTS UNDERGOING ENTECAVIR OR TENOFOVIR TREATMENT
    Lee, Chieh-Ju
    Su, Chien-Wei
    Lin, Han-Chieh
    Hou, Ming-Chih
    Huang, Yi-Hsiang
    HEPATOLOGY, 2019, 70 : 578A - 579A
  • [42] Comparable Incidence of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated with Entecavir or Tenofovir
    Shin, Jung Woo
    Jeong, Joonho
    Jung, Seok Won
    Lee, Seung Bum
    Park, Bo Ryung
    Kim, Min-Ju
    Park, Eun Ji
    Park, Neung Hwa
    DIGESTIVE DISEASES AND SCIENCES, 2021, 66 (05) : 1739 - 1750
  • [43] Comparison of Tenofovir and Entecavir in the Prevention of Hepatocellular Carcinoma Occurrence in Patients with Chronic Hepatitis B
    Facciorusso, Antonio
    Cincione, Ivan
    Sacco, Rodolfo
    LIVER CANCER, 2021, 10 (03) : 285 - 286
  • [44] Real-world efficacy of long-term entecavir and tenofovir in patients with chronic hepatitis B
    Le, S.
    Ratnam, D.
    Van Leest, R.
    Kemp, W.
    Roberts, S.
    Nicoll, A.
    Gow, P.
    Bell, S.
    Sood, S.
    Arachchi, N.
    Lubel, J.
    Ryan, M.
    Howell, J.
    Majeed, A.
    Dev, A.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 95 - 95
  • [45] Long-term effects of entecavir and tenofovir treatment on the fibrotic burden in patients with chronic hepatitis B
    Chon, Young Eun
    Kim, Seung Up
    Seo, Yeon Seok
    Lee, Hye Won
    Lee, Han Ah
    Kim, Mi Na
    Roh, Yun Ho
    Park, Jun Yong
    Kim, Do Young
    Ahn, Sang Hoon
    Tak, Won Young
    Park, Soo Young
    Kim, Beom Kyung
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2022, 37 (01) : 200 - 207
  • [46] Reduced Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Receiving Long-Term Besifovir Therapy
    Yim, Hyung Joon
    Kang, Seong Hee
    Jung, Young Kul
    Ahn, Sang Hoon
    Kim, Won
    Yang, Jin Mo
    Jang, Jae Young
    Kweon, Yong Oh
    Cho, Yong Kyun
    Kim, Yoon Jun
    Hong, Gun Young
    Kim, Dong Joon
    Sohn, Joo Hyun
    Lee, Jin Woo
    Park, Sung Jae
    Yim, Sun Young
    Park, Jin Kyung
    Um, Soon Ho
    CANCERS, 2024, 16 (05)
  • [47] Tenofovir versus entecavir in prevention of hepatocellular carcinoma and mortality in patients with chronic hepatitis B
    Kamal, Faisal
    Khan, Muhammad Ali
    Ahmed, Aijaz
    Nair, Satheesh
    GUT, 2020, 69 (11) : 2054 - +
  • [48] Impact of Long-Term Tenofovir Disoproxil Fumarate on Incidence of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B
    Kim, W. Ray
    Loomba, Rohit
    Berg, Thomas
    Schall, Raul E. Aguilar
    Yee, Leland J.
    Dinh, Phillip V.
    Flaherty, John F.
    Martins, Eduardo B.
    Therneau, Terry M.
    Jacobson, Ira
    Fung, Scott
    Gurel, Selim
    Buti, Maria
    Marcellin, Patrick
    CANCER, 2015, 121 (20) : 3631 - 3638
  • [49] Undesirable Long-Term Outcome of Entecavir Therapy in Chronic Hepatitis B With Cirrhosis Reply
    Fan, Rong
    Hou, Jinlin
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 18 (09) : 2177 - 2148
  • [50] Decreasing risk of hepatocellular carcinoma (HCC) development after the first 5 years of entecavir (ETV) or tenofovir (TDF) therapy in Caucasian chronic hepatitis B (CHB) patients
    Papatheodoridis, George V.
    Idilman, Ramazan
    Dalekos, George N.
    Buti, Maria
    Chi, Heng
    van Boemmel, Florian
    Luis Calleja, Jose
    Sypsa, Vana
    Goulis, Ioannis
    Manolakopoulos, Spilios
    Invernizzi, Federica
    Siakavellas, Spyros I.
    Keskin, Onur
    Gatselis, Nikolaos
    Hansen, Bettina E.
    Lehretz, Maria
    de la Revilla, Juan
    Savvidou, Savvoula
    Kourikou, Anastasia
    Facchetti, Floriana
    Vlachogiannakos, Jiannis
    Galanis, Kostas
    Yurdaydin, Cihan
    Berg, Thomas
    Colombo, Massimo
    Esteban, Rafael
    Janssen, Harry L.
    Lampertico, Pietro
    HEPATOLOGY, 2015, 62 : 1188A - 1189A
12345